A recent analysis has concluded that the antidepressant medication escitalopram demonstrates greater efficacy in stopping patient relapses compared to Prozac.

The evaluation determined that escitalopram, alongside two other unnamed medications, ranked highest in keeping patients well during treatment evaluations.

Additional information concerning the findings and the scope of the evaluation is expected to emerge as the story develops.